Probing Isoform Switching Events in Various Cancer Types: Lessons From Pan-Cancer Studies

Tülay Karakulak1,2,3, Holger Moch2,4, Christian von Mering1,3

  • 1Department of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.

Insights

Alternative splicing regulates gene expression and protein diversity. In cancer, altered splicing creates distinct protein isoforms, impacting disease progression and therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Genomics
  • Bioinformatics

Background:

  • Alternative splicing is a key regulator of gene expression in mammals, generating protein diversity.
  • Dysregulation of alternative splicing is a hallmark of cancer, leading to altered protein isoform expression.
  • Recent advances in sequencing and analysis have revealed the extent and impact of aberrant splicing in cancer.

Purpose of the Study:

  • To review the molecular mechanisms of alternative splicing.
  • To describe the role of alternative splicing in healthy tissues and its disruption in cancer.
  • To compare computational tools and pan-cancer study strategies for analyzing splicing events.

Main Methods:

  • Literature review of molecular mechanisms and functions of alternative splicing.
  • Summary of computational tools for analyzing differential transcript usage and isoform switching.
  • Comparative analysis of recent pan-cancer studies on isoform switching events.

Main Results:

  • Alternative splicing contributes to protein, cellular, and species diversity.
  • Cancer-specific splicing events lead to pathogenic protein isoforms.
  • Comparison of pan-cancer studies highlights methodological similarities and discrepancies.

Conclusions:

  • Understanding disrupted alternative splicing in cancer is crucial for diagnostics and therapeutics.
  • Development of robust methods for cancer-specific transcript detection is needed.
  • Improved prediction of functional impacts of isoform switching events will advance cancer research.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.5K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.6K